Development of propranolol hydrochloride matrix tablets: An investigation on effects of combination of hydrophilic and hydrophobic matrix formers using multiple comparison analysis

International Journal of Pharmaceutical Sciences Review and Research

Volumn 1, Issue 2, 2010, Pages 1-7

  Khandai, Madhusmruti ^a   Chakraborty, Santanu ^a   Sharma, Anuradha ^a   Panda, Debashisha ^a   Khanam, Nazia ^a   Panda, Santosh Kumar ^a  

^a Department of Pharmaceutics   (India)

Author keywords

Diffusion; Erosion; Propranolol hydrochloride; Statistical analysis

Indexed keywords

ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; PROPRANOLOL;

ARTICLE; CHEMICAL INTERACTION; COMPARATIVE STUDY; DRUG CONTENT; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MATRIX TABLET; SUSTAINED RELEASE PREPARATION; TABLET COMPRESSION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET PROPERTY; TABLET THICKNESS; WATER TRANSPORT; WEIGHT;

EID: 79951980629     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. George M, Grass IV, Robinson JR. Sustained and Controlled release drug delivery systems. Marcel Dekker, New York, 1978, 124-127.
2. Martindale. The Extra Pharmacopoeia. 31st edn. The Pharmaceutical Press, London, 1996, 936-937.
3. Cid E, Mella F, Lucchini L, Carcamo M, Monasterio J. Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man. Biopharm. Drug. Dispos. 1986, 7, 559-566.
4. Walle T, Conradi EC, Walle UK, Fagan TC, Gaffney TE. The predictable relationship between plasma levels and dose during chronic propranolol therapy. Clin. Pharmacol. Ther. 1978, 24, 668-677.
5. Buket T, Yilmaz C, Olgun G, Sirri K, Atilla HA. Design and evaluation of sustained release and buccal adhesive Propranolol hydrochloride tablets. J. Control. Release. 1996, 38, 11-20.
6. Salsa T, Veiga F, Pina ME. Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug. Dev. Ind. Pharm. 1997, 23, 929-938.
7. Alderman DA. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int. J. Pharm. Tech. Prod Mfr. 1984, 5, 1-9.
8. Mazer N, Abisch E, Gfeller J. Intra-gastric behavior and absorption kinetics of a normal and floating modified-release capsule of isradipine under fasted and fed conditions. J. Pharm. Sci. 1988, 77, 647-657.
9. Chen GL, Hao WH. In-vitro performance of floating sustained-release capsule of Verapamil. Drug Dev. Ind. Pharm. 1998, 24, 1067-1072.
10. Liu J, Zhang F, McGinity JW. Properties of lipophilic matrix tablets containing phenylpropanilamine hydrochloride prepared by hot-melt extrusion. Eur. J. Pharm. Biopharm. 2001, 52, 181-190.
11. Government of Indian. Ministry of Health and Family Welfare. Indian Pharmacopoeia. The controller of Publications, New Delhi, India, 1996, Vol 2, 736.
12. Government of Indian. Ministry of Health and Family Welfare. Indian Pharmacopoeia. The controller of Publications, New Delhi, India, 1996, Vol 2, 634-635.
13. Reynold TD, Gehrke SH, Hussain AS, Shenonda LS. Polymer erosion and drug release characterization of hydroxypropyl methylcellulose matrices. J. Pharm. Sci. 1998, 87, 1115-1123.
14. Merchant HA, Shoaib HM, Tazeen J, Yousuf RI. Once-daily tablet formulation and in-vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: A technical note. AAPS. Pharm. Sci. Tech. 2006, 7 (3), E1-E6, Article 78, DOI: 10.1208/pt070378.
15. Bourne DW. Pharmacokinetics. In: Banker GS and Rhodes CT. (eds.) Modern Pharmaceutics. 4th edn. Marcel Dekker, New York, 2002, 67-92.
16. Higuchi T. Mechanism of sustained action medication. J. Pharm. Sci. 1963, 52, 1145-49.
17. Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Release. 1987, 5, 37-42.
18. Korsmeyer RW, Gurny R, Docler E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15, 25-35.
19. Katikaneni PR, Upadrashia SM, Neau SH, Mitra AK. Ethyl cellulose matrix controlled-release tablets of a water soluble drug. Int. J. Pharm. 1995, 123, 119-125.
20. Ebube NK, Hikal A, Wyandt CM, Beer DC, Miller LG, Jones AB. Sustained release of acetaminophen from heterogeneous matrix tablets, influence of polymer ratio, polymer loading and coactive on drug release. Pharm. Dev. Technol. 1997, 2, 161-170.
21. Kuksal A, Tiwary AK, Jain NK, Jain S. Formulation and in-vitro evaluation of extended-release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers. AAPS. Pharm. Sci. Tech. 2006, 7(1), E1-E9, Article 1, DOI:10.1208/pt070101.
22. Efentakis M, Koutlis A. Release of furosemide from multiple unit and single unit preparations containing different viscosity grades of sodium alginate. Pharm. Dev. Technol. 2001, 6, 91-98.
23. Mockel JE, Lippold BC. Zero order release from hydrocolloid matrices. Pharm. Res. 1993, 10, 1066-1070.